Accuracy of volume and DVH parameters determined with different brachytherapy treatment planning systems

Radiotherapy and Oncology

Volumn 84, Issue 3, 2007, Pages 290-297

  Kirisits, Christian ^a   Siebert, Frank André ^b   Baltas, Dimos ^c   De Brabandere, Marisol ^d   Hellebust, Taran Paulsen ^e   Berger, Daniel ^a   Venselaar, Jack ^f  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Klinikum Offenbach GmbH   (Germany)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

Author keywords

Brachytherapy; Dose volume histogram calculation; Treatment planning

Indexed keywords

ARTICLE; BRACHYTHERAPY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

BRACHYTHERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PHANTOMS, IMAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 34548382663     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.06.010     Document Type: Article

References (19)

1. Akimoto T., Katoh H., Noda S.E., et al. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 63 (2005) 472-478
2. Ash D., Flynn A., Battermann J., et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57 (2000) 315-321
3. Ash D., Al-Qaisieh B., Bottomley D., Carey B., and Joseph J. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. Radiother Oncol 79 (2006) 185-189
4. Butler W.M., Merrick G.S., Dorsey A.T., and Hagedorn B.M. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 575-582
5. Crook J., Milosevic M., Catton P., et al. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy 1 (2002) 66-73
6. Crook J.M., Potters L., Stock R.G., and Zelefsky M.J. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. Brachytherapy 4 (2005) 186-194
7. Fellner C., Sommer B., Siedhoff N., and Pötter R. Berechnungsgenauigkeit von Volumina zur Evaluierung von Dosis-Volumen-Histogrammen. Vergleich verschiedener Bestrahlungsplanungssysteme. Strahlenther Onkol 174 (1998) 345-349
8. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (I): concepts and terms in 3D image-based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
9. Han B.H., Wallner K., Merrick G., Badiozamani K., and Butler W. The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters. Med Phys 30 (2003) 096-102
10. Hellebust T.P., Dale E., Skjonsberg A., et al. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 60 (2001) 273-280
11. Herman G.T., Zheng J., and Bucholtz C.A. Shape-based interpolation. IEEE Comput Graph Appl 12 (1992) 69-79
12. Kim R.Y., and Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms. Brachytherapy 2 (2003) 200-206
13. Kirisits C., Pötter R., Lang S., et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
14. Kovacs G., Pötter R., Loch T., et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 75 (2005) 137-148
15. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy post-implant dosimetric analysis. Int J Radiat Oncol Biol Phys 46 (2000) 221-230
16. Pelloski C.E., Palmer M., Chronowski G.M., Jhingran A., Horton J., and Eifel P.J. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 131-137
17. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy: 3D dose volume parameters and aspects of 3D image based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
18. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50 (2001) 605-614
19. 192Ir sources. Med Phys 22 (1995) 809-819